Allurion Technologies (ALURW) Share-based Compensation (2022 - 2026)
Allurion Technologies (ALURW) reported Share-based Compensation of $638000.0 for Q1 2026, down 28.87% on a YoY basis from $897000.0 in Q1 2025, and down 9.12% quarter-over-quarter from $702000.0 in Q4 2025.
Allurion Technologies (ALURW) Share-based Compensation (2022 - 2026) Analysis & Trends
Allurion Technologies has reported Share-based Compensation for 5 years, with the latest figure at $638000.0 in Q1 2026.
- For the quarter ending Q1 2026, Share-based Compensation fell 28.87% year-over-year to $638000.0; the trailing twelve-month figure through Mar 2026 stood at $2.9 million (down 15.11% YoY), and the FY2025 full-year result was $3.1 million, up 2.95% from the prior year.
- Share-based Compensation for Q1 2026 stood at $638000.0, down from $702000.0 in the prior quarter.
- The five-year high for Share-based Compensation was $5.5 million in Q3 2023, with the low at $89000.0 in Q2 2022.
- Historically, Share-based Compensation has averaged $972562.5 across 5 years, with a median of $670000.0 in 2025.
- Annual changes were most pronounced in 2023 — Share-based Compensation jumped 5855.91% — and 2024, when it plunged 84.47%.
- Allurion Technologies' Share-based Compensation stood at $182000.0 in 2022, then surged by 1003.3% to $2.0 million in 2023, then sank by 58.22% to $839000.0 in 2024, then declined by 16.33% to $702000.0 in 2025, then slipped by 9.12% to $638000.0 in 2026.
- The last three Share-based Compensation figures came in at $638000.0 (Q1 2026), $702000.0 (Q4 2025), and $531000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 87.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 94.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 35.12 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 43.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 12.90 Mn |
| 10 | Allurion Technologies | - | - | 1.23 Mn | 638,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 638,000.00 |
| Mar 31, 2026 | 638,000.00 |
| Dec 31, 2025 | 702,000.00 |
| Dec 31, 2025 | 702,000.00 |
| Sep 30, 2025 | 531,000.00 |
| Sep 30, 2025 | 531,000.00 |
| Jun 30, 2025 | 1.02 Mn |
| Jun 30, 2025 | 1.02 Mn |
| Mar 31, 2025 | 897,000.00 |
| Mar 31, 2025 | 897,000.00 |
| Dec 31, 2024 | 839,000.00 |
| Dec 31, 2024 | 839,000.00 |
| Sep 30, 2024 | 860,000.00 |
| Sep 30, 2024 | 860,000.00 |
| Jun 30, 2024 | 805,000.00 |
| Jun 30, 2024 | 805,000.00 |
| Mar 31, 2024 | 552,000.00 |
| Mar 31, 2024 | 552,000.00 |
| Dec 31, 2023 | 2.01 Mn |
| Dec 31, 2023 | 2.01 Mn |